ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

No reported Net Debt figures are available to summarize.

Net Debt history

Currency unavailable · from the balance sheet

No Net Debt data reported for this period type.

Net Debt vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Net Debt for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRMEPrime Medicine, Inc.Mar 2026$50.41M USD+72.2%—17.1%
MGTXMeiraGTx Holdings plcMar 2026$15.99M USD+11.4%—6.5%
SLNSilence Therapeutics plcMar 2026-$5.52M USD+91.5%—4.8%
PRQRProQR Therapeutics N.V.Mar 2026-€67.47M EUR+46.8%—68.1%
STOKStoke Therapeutics, Inc.Mar 2026-$152.24M USD+44.1%—34.3%
BNTCBenitec Biopharma Inc.Mar 2026-$183.89M USD-79.2%—98.3%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026-$187.39M USD-7.5%—76.4%
RNAAtrium Therapeutics, Inc.Mar 2026-$265.17M USD——90.7%
WVEWave Life Sciences Ltd.Mar 2026-$528.88M USD-141.0%—90.6%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+27.8%—68.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.